Journal ArticleOPEN ACCESS

Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India

Human Vaccines and Immunotherapeutics (2013) 9(1) 125-127
DOI: 10.4161/hv.22421
4Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The healthcare workers having seroprotection at 3 weeks (n = 127) following Pandemic H1N1 2009 influenza vaccination were followed up for antibody persistence. Seroprotection at 12 mo (60.2%) was significantly lower as compared with 3 weeks (74.7%), 3 mo (77.8%) and 6 mo (75.4%). The vaccine provided seroprotection up to one year. © 2013 Landes Bioscience.

Author supplied keywords

Cite

CITATION STYLE

APA

Tandale, B. V., Pawar, S. D., Gurav, Y. K., Parkhi, S. S., & Mishra, A. C. (2013). Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India. Human Vaccines and Immunotherapeutics, 9(1), 125–127. https://doi.org/10.4161/hv.22421

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free